Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex

Neuroscience

Volumn 169, Issue 4, 2010, Pages 1651-1661

  Eggan, S M ^a   Melchitzky, D S ^a,b   Sesack, S R ^a   Fish, K N ^a   Lewis, D A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MERCYHURST COLLEGE   (United States)

Author keywords

Cannabis; GABA; Parvalbumin; Primate; Schizophrenia; Working memory

Indexed keywords

CANNABINOID 1 RECEPTOR; CHOLECYSTOKININ;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC SPINE; ELECTRON MICROSCOPY; IMMUNOCYTOCHEMISTRY; MACACA; MALE; NEOCORTEX; NERVE ENDING; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; SPECIES DIFFERENCE; SYNAPSE;

EID: 77955432341     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.011     Document Type: Article

References (64)

1. Bacci A., Huguenard J.R., Prince D.A. Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 2004, 431:312-316.
2. Bodor A.L., Katona I., Nyiri G., Mackie K., Ledent C., Hajos N., Freund T.F. Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 2005, 25:6845-6856.
3. Celio M.R., Baier W., Schärer L., de Viragh P.A., Gerday Ch Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium 1988, 9:81-86.
4. Chattopadhyaya B., Di Cristo G., Wu C.Z., Knott G., Kuhlman S., Fu Y., Palmiter R.D., Huang Z.J. GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron 2007, 54:889-903.
5. Connors B.W., Long M.A. Electrical synapses in the mammalian brain. Annu Rev Neurosci 2004, 27:393-418.
6. Cruz D.A., Eggan S.M., Lewis D.A. Postnatal development of pre- and post-synaptic GABA markers at chandelier cell inputs to pyramidal neurons in monkey prefrontal cortex. J Comp Neurol 2003, 465:385-400.
7. D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.T., Braley G., Gueorguieva R., Krystal J.H. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2004, 29:1558-1572.
8. DeFelipe J., González-Albo M.C., del Río M.R., Elston G.N. Distribution and patterns of connectivity of interneurons containing calbindin, calretinin, and parvalbumin in visual areas of the occipital and temporal lobes of the macaque monkey. J Comp Neurol 1999, 412:515-526.
9. Egertová M., Elphick M.R. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J Comp Neurol 2000, 422:159-171.
10. Eggan S.M., Hashimoto T., Lewis D.A. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry 2008, 65:772-784.
11. Eggan S.M., Lewis D.A. Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 2007, 17:175-191.
12. Foldy C., Lee S.Y., Szabadics J., Neu A., Soltesz I. Cell type-specific gating of perisomatic inhibition by cholecystokinin. Nat Neurosci 2007, 10:1128-1130.
13. Freund T.F., Katona I. Perisomatic inhibition. Neuron 2007, 56:33-42.
14. Freund T.F., Katona I., Piomelli D. Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 2003, 83:1017-1066.
15. Galarreta M., Erdelyi F., Szabo G., Hestrin S. Electrical coupling among irregular-spiking GABAergic interneurons expressing cannabinoid receptors. J Neurosci 2004, 24:9770-9778.
16. Geola F.L., Hershman J.M., Warwick R., Reeve J.R., Walsh J.H., Tourtellotte W.W. Regional distribution of cholecystokinin-like immunoreactivity in the human brain. J Clin Endocrinol Metab 1981, 53:270-275.
17. Glass M., Dragunow M., Faull R.L. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997, 77:299-318.
18. Glickfeld L.L., Scanziani M. Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 2006, 9:807-815.
19. Goldman-Rakic P.S. Cellular basis of working memory. Neuron 1995, 14:477-485.
20. Hajos M., Hoffmann W.E., Kocsis B. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 2008, 63:1075-1083.
21. Hajos N., Katona I., Naiem S.S., Mackie K., Ledent C., Mody I., Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 2000, 12:3239-3249.
22. Haller J., Matyas F., Soproni K., Varga B., Barsy B., Nemeth B., Mikics E., Freund T.F., Hajos N. Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur J Neurosci 2007, 25:2445-2456.
23. Hashimoto T., Arion D., Unger T., Maldonado-Aviles J.G., Morris H.M., Volk D.W., Mirnics K., Lewis D.A. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2008, 13:147-161.
24. Hefft S., Jonas P. Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci 2005, 8:1319-1328.
25. Hendry S.H.C., Jones E.G., Beinfeld M.C. Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels. Proc Natl Acad Sci U S A 1983, 80:2400-2404.
26. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H.U., van Os J. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005, 330:11-16.
27. Howard M.W., Rizzuto D.S., Caplan J.B., Madsen J.R., Lisman J., Aschenbrenner-Scheibe R., Schulze-Bonhage A., Kahana M.J. Gamma oscillations correlate with working memory load in humans. Cereb Cortex 2003, 13:1369-1374.
28. Hsu S.-M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580.
29. Hungund B.L., Basavarajappa B.S. Distinct differences in the cannabinoid receptor binding in the brain of C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. J Neurosci Res 2000, 60:122-128.
30. Karson M.A., Tang A.H., Milner T.A., Alger B.E. Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus. J Neurosci 2009, 29:4140-4154.
31. Karson M.A., Whittington K.C., Alger B.E. Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others. Neuropharmacology 2008, 54:117-128.
32. Katona I., Sperlagh B., Sik A., Kafalvi A., Vizi E.S., Mackie K., Freund T.F. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 1999, 19:4544-4558.
33. Katona I., Urban G.M., Wallace M., Ledent C., Jung K.M., Piomelli D., Mackie K., Freund T.F. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 2006, 26:5628-5637.
34. Kawaguchi Y., Kubota Y. Neurochemical features and synaptic connections of large physiologically-identified GABAergic cells in the rat frontal cortex. Neuroscience 1998, 85:677-701.
35. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci 2006, 26:2991-3001.
36. Kisvarday Z.F., Martin K.A., Whitteridge D., Somogyi P. Synaptic connections of intracellularly filled clutch cells: a type of small basket cell in the visual cortex of the cat. J Comp Neurol 1985, 241:111-137.
37. Klausberger T., Marton L.F., O'Neill J., Huck J.H., Dalezios Y., Fuentealba P., Suen W.Y., Papp E., Kaneko T., Watanabe M., Csicsvari J., Somogyi P. Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci 2005, 25:9782-9793.
38. Kovacs T.O., Walsh J.H., Maxwell V., Wong H.C., Azuma T., Katt E. Gastrin is a major mediator of the gastric phase of acid secretion in dogs: proof by monoclonal antibody neutralization. Gastroenterology 1989, 97:1406-1413.
39. Kubota Y., Kawaguchi Y. Two distinct subgroups of cholecystokinin-immunoreactive cortical interneurons. Brain Res 1997, 752:175-183.
40. Lewis D.A., Campbell M.J., Morrison J.H. An immunohistochemical characterization of somatostatin-28 and somatostatin-28 (1-12) in monkey prefrontal cortex. J Comp Neurol 1986, 248:1-18.
41. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005, 6:312-324.
42. Lund J.S., Lewis D.A. Local circuit neurons of developing and mature macaque prefrontal cortex: golgi and immunocytochemical characteristics. J Comp Neurol 1993, 328:282-312.
43. Marsicano G., Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 1999, 11:4213-4225.
44. McGuire B.A., Gilbert C.D., Rivlin P.K., Wiesel T.N. Targets of horizontal connections in macaque primary visual cortex. J Comp Neurol 1991, 305:370-392.
45. Melchitzky D.S., Eggan S.M., Lewis D.A. Synaptic targets of calretinin-containing axon terminals in macaque monkey prefrontal cortex. Neuroscience 2005, 130:185-195.
46. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370:319-328.
47. Murray R.M., Morrison P.D., Henquet C., Di Forti M. Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 2007, 8:885-895.
48. Oeth K.M., Lewis D.A. Cholecystokinin innervation of monkey prefrontal cortex: an immunohistochemical study. J Comp Neurol 1990, 301:123-137.
49. Oeth K.M., Lewis D.A. Postnatal development of the cholecystokinin innervation of monkey prefrontal cortex. J Comp Neurol 1993, 336:400-418.
50. Peters A., Palay S.L., Webster D.F. The fine structure of the nervous system 1991, Oxford University Press, New York, NY.
51. Puighermanal E., Marsicano G., Busquets-Garcia A., Lutz B., Maldonado R., Ozaita A. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci 2009, 12:1152-1158.
52. A blockade of prefrontal cortical neurons engaged by working memory. J Neurosci 2000, 20:485-494.
53. Rehfeld J.F. Localisation of gastrins to neuro- and adenohypophysis. Nature 1978, 271:771-773.
54. Robbe D., Montgomery S.M., Thome A., Rueda-Orozco P.E., McNaughton B.L., Buzsaki G. Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci 2006, 9:1526-1533.
55. Saper C.B. An open letter to our readers on the use of antibodies. J Comp Neurol 2005, 493:477-478.
56. Saper C.B., Sawchenko P.E. Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 2003, 465:161-163.
57. Sawaguchi T., Matsumura M., Kubota K. Delayed response deficit in monkeys by locally disturbed prefrontal neuronal activity by bicuculline. Behav Brain Res 1988, 31:193-198.
58. Schneider M., Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology 2003, 28:1760-1769.
59. Sesack S.R., Hawrylak V.A., Matus C., Guido M.A., Levey A.I. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 1998, 18:2697-2708.
60. Sesack S.R., Snyder C.L., Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine-hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol 1995, 363:264-280.
61. Smiley J.F., Goldman-Rakic P.S. Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. Cereb Cortex 1993, 3:223-238.
62. Trettel J., Fortin D.A., Levine E.S. Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol 2004, 556:95-107.
63. Winsauer P.J., Lambert P., Moerschbaecher J.M. Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav Pharmacol 1999, 10:497-511.
64. Zaitsev A.V., Gonzalez-Burgos G., Povysheva N.V., Kroner S., Lewis D.A., Krimer L.S. Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex 2005, 15:1178-1186.